• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Division of Oncology Products 2 (DOP2)

Director: Patricia Keegan, M.D.
Deputy Director: Joseph Gootenberg, M.D.
Deputy Director of Safety: Jeffrey Summers, M.D.

SRRM: Vacant

Chief, Project Management Staff: Karen Jones
Chief Project Management Staff: Monica Hughes
Secretary: (Vacant)

The Division of Oncology Products 2 (DOP2) regulates Investigational New Drug Applications (INDs), New Drug Applications (NDAs) and Biologic Licensing Applications (BLAs) for the following therapeutic areas:

  1. Gastrointestinal Cancers
  2. Lung/Head & Neck Cancers
  3. Neuro-oncology/Rare cancers/Pediatric Solid Tumor
  4. Melanoma/Sarcoma

Mailing Address:

Food and Drug Administration
Center for Drug Evaluation and Research
Division of Oncology Products 2 (DOP2)
5901-B Ammendale Road
Beltsville, MD 20705-1266

Phone: (301) 796-2320
Fax: (301) 796-9849